Purdue University President Mitch Daniels and Purdue Research Foundation President Brian Edelman have appointed David Broecker as the foundation’s chief innovation and collaboration officer.

Broecker has a long history of industry and entrepreneurial experience at Fortune 500 and startup medical device and biotechnology companies in Indianapolis and the Boston area. He will oversee strategic innovation and collaboration initiatives at the Purdue Research Foundation, a private, nonprofit foundation established in 1930 to advance the mission of Purdue University.

Broecker continues to serve as chief executive officer and chairman for Zorion Medical, a medical device startup he founded and located to Indianapolis. He recently served as founding president and CEO of the Indiana Biosciences Research Institute, where he helped raise more than $120 million in funding, recruited world-class scientific and operational talent and spearheaded several early and successful university and industry partnerships.

Broecker also previously served as president and CEO of Alkermes, a global biopharmaceutical company in Cambridge, Massachusetts, developing innovative medicines for the treatment of central nervous system diseases. He has founded several life science companies, provided executive leadership, and is a board member to multiple startups.

Broecker began his career at Eli Lilly and Co. as a process engineer, but quickly assumed leadership positions throughout the company. He graduated summa cum laude from Wabash College, is a member of Phi Beta Kappa, and was a four-year starter on the football team. Broecker holds a graduate degree in chemical engineering from the Massachusetts Institute of Technology and an MBA from the University of Chicago.